Stockreport

Adamas Pharma's Gocovri shows long-term treatment effect in late-stage Parkinson's study [Seeking Alpha]

Adamas Pharmaceuticals, Inc.  (ADMS) 
Last adamas pharmaceuticals, inc. earnings: 2/25 04:03 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.adamaspharma.com/investors
PDF Final results from a two-year open-label Phase 3 clinical trial, EASE LID 2 , evaluating Adamas Pharmaceuticals' ( ADMS ) GOCOVRI (amantadine) in patients wi [Read more]